Align Technology, Inc. $ALGN Shares Purchased by Czech National Bank

Czech National Bank lifted its stake in shares of Align Technology, Inc. (NASDAQ:ALGN) by 3.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 16,654 shares of the medical equipment provider’s stock after acquiring an additional 537 shares during the quarter. Czech National Bank’s holdings in Align Technology were worth $3,153,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Parallel Advisors LLC boosted its stake in shares of Align Technology by 66.0% in the second quarter. Parallel Advisors LLC now owns 1,044 shares of the medical equipment provider’s stock valued at $198,000 after buying an additional 415 shares in the last quarter. Voya Investment Management LLC grew its holdings in Align Technology by 23.3% in the first quarter. Voya Investment Management LLC now owns 81,297 shares of the medical equipment provider’s stock valued at $12,915,000 after purchasing an additional 15,355 shares during the period. Militia Capital Partners LP acquired a new position in shares of Align Technology in the 1st quarter valued at about $3,670,000. Inspire Investing LLC raised its position in Align Technology by 59.8% in the first quarter. Inspire Investing LLC now owns 2,013 shares of the medical equipment provider’s stock valued at $320,000 after purchasing an additional 753 shares during the period. Finally, Strs Ohio acquired a new stake in Align Technology during the 1st quarter valued at $794,000. 88.43% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

ALGN has been the topic of several recent analyst reports. Piper Sandler cut their price target on shares of Align Technology from $250.00 to $190.00 and set an “overweight” rating on the stock in a report on Thursday, July 31st. Stifel Nicolaus decreased their target price on Align Technology from $275.00 to $200.00 and set a “buy” rating on the stock in a report on Thursday, July 31st. Mizuho set a $210.00 price target on shares of Align Technology in a report on Thursday, July 31st. Evercore ISI increased their price target on shares of Align Technology from $200.00 to $220.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 9th. Finally, Zacks Research cut Align Technology from a “hold” rating to a “strong sell” rating in a research report on Monday, September 1st. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $215.00.

Align Technology Stock Performance

ALGN opened at $131.39 on Friday. The company has a fifty day moving average price of $153.82 and a two-hundred day moving average price of $168.44. The firm has a market capitalization of $9.52 billion, a PE ratio of 22.16, a P/E/G ratio of 1.49 and a beta of 1.65. Align Technology, Inc. has a 52 week low of $127.70 and a 52 week high of $260.35.

Align Technology (NASDAQ:ALGN) last posted its quarterly earnings results on Wednesday, July 30th. The medical equipment provider reported $2.49 earnings per share for the quarter, missing analysts’ consensus estimates of $2.57 by ($0.08). Align Technology had a net margin of 11.04% and a return on equity of 13.36%. The company had revenue of $1.01 billion during the quarter, compared to analyst estimates of $1.06 billion. During the same period last year, the company earned $2.41 EPS. The business’s revenue for the quarter was down 1.6% compared to the same quarter last year. Align Technology has set its Q3 2025 guidance at EPS. Equities analysts forecast that Align Technology, Inc. will post 7.98 EPS for the current year.

Align Technology declared that its board has initiated a share buyback program on Tuesday, August 5th that permits the company to buyback $200.00 million in shares. This buyback authorization permits the medical equipment provider to reacquire up to 2% of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s management believes its shares are undervalued.

Insider Transactions at Align Technology

In related news, CEO Joseph M. Hogan bought 7,576 shares of the company’s stock in a transaction on Friday, August 1st. The shares were purchased at an average cost of $131.49 per share, for a total transaction of $996,168.24. Following the acquisition, the chief executive officer owned 184,945 shares of the company’s stock, valued at approximately $24,318,418.05. This represents a 4.27% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 0.66% of the company’s stock.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.